A phase II study of palonosetron to prevent nausea and vomiting induced by chemotherapy in haematological malignancies.
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Palonosetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 15 Jun 2013 New trial record